MHRA

UK patients get early access to Alnylam’s ultra-rare disease drug lumasiran

https://pharmaphorum.com/news/uk-patients-get-early-access-to-alnylams-ultra-rare-disease-drug-lumasiran/

UK stops recruitment to hydroxychloroquine COVID-19 trials

https://pharmaphorum.com/news/uk-stops-recruitment-to-hydroxychloroquine-covid-19-trials/

UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients

https://pharmaphorum.com/news/uk-okays-early-access-to-gileads-remdesivir-in-seriously-ill-covid-19-patients/

Large UK hospital to tear up paper records amid digitisation drive

https://pharmaphorum.com/news/large-uk-hospital-to-tear-up-paper-records-amid-digitisation-drive/

MHRA says Avastin can be used for AMD despite Bayer, Novartis objections

https://pharmaphorum.com/news/mhra-says-avastin-can-be-used-for-amd-despite-bayer-novartis-objections/

Conference brochure for the inaugural Respiratory Drug Delivery now available

https://pharmaphorum.com/partner-content/conference-brochure-for-the-inaugural-respiratory-drug-delivery-now-available/

Working with EU is ‘preferred option’ post-Brexit says MHRA chief

https://pharmaphorum.com/news/working-with-eu-is-preferred-option-post-brexit-says-mhra-chief/

Market access roundup: UK HTA shakeups as Brexit fears deepen

https://pharmaphorum.com/views-and-analysis/market-access-roundup-uk-hta-shakeups-as-brexit-fears-deepen/

MHRA investigates opioid regulation as addiction crisis deepens

https://pharmaphorum.com/news/mhra-investigates-opioid-regulation-as-addiction-crisis-deepens/

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search